The development of flexible, graded plasma surface engineered coatings for superior interfacial performance. The next generation of intraocular lenses, medical devices to treat patients with cataracts, will be developed through application of advanced surface engineering technologies. These superior coated lenses will improve biocompatibility and function, leading to additional benefit for the forecasted 2.7 million Australians with cataracts by 2021.